Complement and myoblast transfer therapy: Donor myoblast survival is enhanced following depletion of host complement C3 using cobra venom factor, but not in the absence of C5

    Research output: Contribution to journalArticlepeer-review

    19 Citations (Scopus)
    Original languageEnglish
    Pages (from-to)231-239
    JournalImmunology and Cell Biology
    Issue number3
    Publication statusPublished - 2001

    Cite this